TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics.

Candida Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.